<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1379130</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The circadian syndrome is a better predictor for psoriasis than the metabolic syndrome via an explainable machine learning method &#x2014; the NHANES survey during 2005&#x2013;2006 and 2009&#x2013;2014</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Gu</surname>
<given-names>Yunfan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2162285"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Ye</surname>
<given-names>Xinglan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2763951"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Wenting</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1983022"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Shiwei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2764465/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Weiming</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2570138"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zeng</surname>
<given-names>Xianyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2387224"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical college, Huazhong University of Science and Technology</institution>, <addr-line>Wuhan, Hubei</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Dermatology, Suzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine</institution>, <addr-line>Suzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine</institution>, <addr-line>Wuhan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>First Clinical College, Hubei University of Chinese Medicine</institution>, <addr-line>Wuhan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Rasime Kalkan, European University of Lefka, T&#xfc;rkiye</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Emine Ikbal Atli, Trakya University, T&#xfc;rkiye</p>
<p>Cigdem Toprak, Bursa Uluda&#x11f; University, T&#xfc;rkiye</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xianyu Zeng, <email xlink:href="mailto:whzengxianyu@163.com">whzengxianyu@163.com</email>; Weiming Zhang, <email xlink:href="mailto:drzhangweiming@163.com">drzhangweiming@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1379130</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>06</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Gu, Ye, Zhao, He, Zhang and Zeng</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Gu, Ye, Zhao, He, Zhang and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To explore the association between circadian syndrome (CircS) and Metabolic Syndrome (MetS) with psoriasis. Compare the performance of MetS and CircS in predicting psoriasis.</p>
</sec>
<sec>
<title>Methods</title>
<p>An observational study used data from the NHANES surveys conducted in 2005&#x2013;2006 and 2009&#x2013;2014. We constructed three multiple logistic regression models to investigate the relationship between MetS, CircS, and their components with psoriasis. The performance of MetS and CircS in predicting psoriasis was compared using five machine-learning algorithms, and the best-performing model was explained via SHAP. Then, bidirectional Mendelian randomization analyses with the inverse variance weighted (IVW) as the primary method were employed to determine the causal effects of each component.</p>
</sec>
<sec>
<title>Result</title>
<p>A total of 9,531 participants were eligible for the study. Both the MetS (OR = 1.53, 95%CI: 1.07&#x2013;2.17, <italic>P</italic> = 0.02) and CircS (OR = 1.40, 95%CI: 1.02&#x2013;1.91, <italic>P</italic> = 0.039) positively correlated with psoriasis. Each CircS algorithmic model performs better than MetS, with Categorical Features+Gradient Boosting for CircS (the area under the precision-recall curve = 0.969) having the best prediction effect on psoriasis. Among the components of CircS, elevated blood pressure, depression symptoms, elevated waist circumference (WC), and short sleep contributed more to predicting psoriasis. Under the IVW methods, there were significant causal relationships between WC (OR = 1.52, 95%CI: 1.34&#x2212;1.73, P = 1.35e-10), hypertension (OR = 1.68, 95%CI: 1.19&#x2212;2.37, P = 0.003), depression symptoms (OR = 1.39, 95%CI: 1.17&#x2212;1.65, P = 1.51e-4), and short sleep (OR = 2.03, 95%CI: 1.21&#x2013;3.39, p = 0.007) with psoriasis risk.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>CircS demonstrated superior predictive ability for prevalent psoriasis compared to MetS, with elevated blood pressure, depression symptoms, and elevated WC contributing more to the prediction.</p>
</sec>
</abstract>
<kwd-group>
<kwd>metabolic syndrome</kwd>
<kwd>circadian syndrome</kwd>
<kwd>psoriasis</kwd>
<kwd>NHANES</kwd>
<kwd>machine learning</kwd>
<kwd>Mendelian randomization</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="54"/>
<page-count count="13"/>
<word-count count="6342"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Systems Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Psoriasis is an autoimmune disorder that affects 2% of the world&#x2019;s population (<xref ref-type="bibr" rid="B1">1</xref>). It is caused by the interaction of several factors, including immune system disorders, inflammatory mediators from different pathways, autoantigens, psoriasis-associated susceptibility genes, and stimuli from various environmental factors (<xref ref-type="bibr" rid="B2">2</xref>), leading to the overactivation of immune cells and chronic inflammation. With the increasing pressure of life in modern society, the incidence and prevalence of psoriasis are increasing yearly (<xref ref-type="bibr" rid="B3">3</xref>). The intrinsic risk factors of psoriasis, such as hypertension, obesity, diabetes mellitus, endocrine disorder, and stress, received more attention (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Metabolic syndrome (MetS), which includes these risk factors, can be a suitable generalization of metabolic disorders in the human body. Insulin resistance, oxidative stress, and central obesity-related inflammation caused by MetS are all inextricably interconnected with the development of psoriasis (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>Lately, researchers have found that circadian rhythm disruptions, including sleep disorders and depression, exacerbate psoriasis (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>) and are often associated with metabolic syndrome (<xref ref-type="bibr" rid="B9">9</xref>). Nonetheless, these risk factors are often viewed as separate components and not taken into account in connection with MetS. The unhealthy lifestyle of modern society (including a sedentary lifestyle, lack of exercise, constant anxiety and depression, lack of sleep, exposure to light and noise, and high-calorie food) has led to not only metabolic disorders but also circadian imbalances (<xref ref-type="bibr" rid="B10">10</xref>). MetS alone hardly explains these metabolic imbalances caused by circadian rhythm disruption. A new concept, the circadian syndrome (CircS), has been proposed to harmonize these factors (<xref ref-type="bibr" rid="B11">11</xref>). CircS combines depression symptoms and short sleep based on the components of MetS. It has been found to be strongly related to coronary heart disease, stroke, and endocrine disruption (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Therefore, we hypothesize that CircS should be considered a new psoriasis risk group besides MetS and may be able to represent psoriasis caused by unhealthy lifestyle habits better than MetS. To answer this question, We utilized data on the population from the National Health and Nutrition Examination Survey (NHANES) to build machine learning (ML) models. Then, we employed publicly available genetic data within the Mendelian randomization (MR) analysis framework to assess the evidence linking the components of CircS to psoriasis in terms of causal relationships.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<p>Our study was conducted in three stages in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. In the first stage, we conducted three multiple logistic regression between MetS, CircS, and their components with psoriasis using data from the NHANES database to explore their association. In the second stage, we select variables from the first stage and use five ML algorithms to compare the performance of MetS and CircS in predicting psoriasis. Select the best-performing model for interpretation and calculate the importance of each variable in the prediction. In the final stage, we used MR analyses of summary statistics from a genome-wide association study (GWAS) to evaluate the causal effect between the components of CircS and psoriasis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Overall study design of the present study.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1379130-g001.tif"/>
</fig>
<sec id="s2_1">
<label>2.1</label>
<title>Observational study</title>
<sec id="s2_1_1">
<label>2.1.1</label>
<title>Data sources and study population</title>
<p>NHANES is a cross-sectional survey updated biennially by the Centers for Disease Control and Prevention to assess adults&#x2019; and children&#x2019;s health and nutritional status in the United States and track changes over time. Questionnaires, physical examinations, and lab work make up the survey. NHANES provides extensive data that accurately represents the US civilian and noninstitutionalized population through a stratified, clustered, and multistage probability sampling technique that selects from cities, blocks, and households. This survey was approved by the Ethics Review Board of the National Center for Health Statistics, and all participants signed written informed consent.</p>
<p>We enrolled 40,816 participants from four survey cycles (2005&#x2013;2006, 2009&#x2013;2010, 2011&#x2013;2012, 2013&#x2013;2014). The exclusion criteria included: (a) Participants under the age of 20 years; (b) Participants with missing laboratory test data or questionnaires to define MetS and CircS; (c) Participants with pregnant. The final sample for subsequent analysis comprised 9,531 participants. We employed multiple imputations by chained equations with four replications to impute the remaining missing data (<xref ref-type="bibr" rid="B15">15</xref>).</p>
</sec>
<sec id="s2_1_2">
<label>2.1.2</label>
<title>Exposure variable: MetS and CircS</title>
<p>According to the criteria published in 2009 by the International Diabetes Federation Task Force on Epidemiology and Prevention; the National Heart, Lung, and Blood Institute; the American Heart Association; and others (<xref ref-type="bibr" rid="B16">16</xref>), MetS was diagnosed at least three of the following: (1) elevated waist circumference (WC) (&#x2265;102 cm for males, &#x2265;88 cm for females); (2) elevated blood pressure (systolic &#x2265;130 mmHg or diastolic &#x2265;85 mmHg or both) or drug treatment for hypertension; (3) elevated fasting blood glucose (FBG) (&#x2265;100 mg/dL) or drug treatment for elevated FBG; (4) reduced High density lipoprotein cholesterol (HDL-C) (&lt;40 mg/dL for males,&lt;50 mg/dL for females) or drug treatment for reduced HDL-C; (5) elevated triglycerides (TG) (&#x2265;150 mg/dL) or drug treatment for elevated TG.</p>
<p>CircS consisted of seven components: reduced sleep duration, depression symptoms, and the five components of MetS. Participants with &#x2265;4 of the abovementioned components were considered to have CircS.</p>
<p>Self-reported sleep duration&lt;6h/day was considered short sleep. Depression symptoms were defined by the patient health status questionnaire-9 (PHQ-9) (<xref ref-type="bibr" rid="B17">17</xref>). The score of PHQ-9 in 5&#x2013;9, 10&#x2013;14, 15&#x2013;19 and &#x2265;20 represent mild, moderate, moderately severe, and severe depression. Participants with the scores of PHQ-9 &#x2265;5 were considered to have depression symptoms.</p>
</sec>
<sec id="s2_1_3">
<label>2.1.3</label>
<title>Outcome variable: psoriasis</title>
<p>Psoriasis was established by confirming a positive answer to the question, &#x201c;Have you ever been told by a healthcare provider that you had psoriasis?&#x201d;</p>
</sec>
<sec id="s2_1_4">
<label>2.1.4</label>
<title>Covariates collection</title>
<p>We included age, gender, race, educational level, family income, smoking status, and drinking status as covariates based on the literature (<xref ref-type="bibr" rid="B18">18</xref>). Specifically, age was categorized into three stages: 20&#x2013;39, 40&#x2013;59 and &#x2265;60 years. Races included Mexican American, Other Hispanic, non-Hispanic white, non-Hispanic black, and other races. Family income was categorized into three classes based on the family poverty income ratio: low income (&#x2264;1.3), middle income (1.3&#x2013;3.5), and high income (&gt;3.5). The education level was classified into high school graduate or less, some college, and college graduate or above. We categorize participants into three smoking statuses: never (&lt;100 cigarettes in a lifetime), former (&#x2265;100 cigarettes in a lifetime and smoking not at all now), and now (&#x2265;100 cigarettes in a lifetime and smoking some days or every day now). Drinking &#x2265;12 drinks per year is considered drinking status.</p>
</sec>
<sec id="s2_1_5">
<label>2.1.5</label>
<title>Statistical analysis</title>
<p>We performed weighting based on the weights recommended by the NHANES analysis guidelines: the sampling weight for each cycle is equal to the 2-year MEC weight of the fasting subsample/4. Participants&#x2019; continuous variables were characterized using mean values, while categorical variables were described using percentage frequencies. Use student t-test to compare differences in continuity variables between MetS or CircS groups that follow a normal distribution; Use the Mann-Whitney U test for skewed distribution data. Categorical variables were compared using the chi-square test. We built three multiple logistic models to examine the association between CircS or MetS with psoriasis. In the non-adjusted model, no factor was adjusted. In the minimally adjusted model, age, gender, and race were adjusted. In the fully adjusted model, age, gender, race, educational level, family income, smoking status, and drinking status were all adjusted. On that basis, we further analyzed the correlation between the components of circs and psoriasis. All statistical analyses were performed in the R environment (version 4.3.2). We calculated the odds ratio (OR) and 95% confidence interval (CI), and <italic>P</italic>&lt; 0.05 (two-sided) was defined as the threshold for statistical significance.</p>
</sec>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Machine learning</title>
<sec id="s2_2_1">
<label>2.2.1</label>
<title>ML model strategies</title>
<p>To compare the predictive value of CircS and MetS for psoriasis, we incorporated all covariates and each component of CircS or MetS in the ML dataset. Five ML algorithms, k-nearest neighbor classification (KNN), support vector machine (SVM), eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), Categorical Features+Gradient Boosting (CatBoost) are used for model construction. The dataset was randomly split into two disjoint sets: a training set (80% of the total data) and a test set (the remaining 20% of the data not in the training set) using the Pareto principle (<xref ref-type="bibr" rid="B19">19</xref>). In the training dataset, we used Bayesian optimization with a fivefold cross-validation to perform automatic hyperparameter tuning for each model. For the purpose of testing the training models, we used the testing sets to compare the performance of CircS and MetS models. The following performance metrics were used: <inline-formula>
<mml:math display="inline" id="im1">
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> <inline-formula>
<mml:math display="inline" id="im2">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> <inline-formula>
<mml:math display="inline" id="im3">
<mml:mrow>
<mml:mi>f</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>&#xd7;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>. TP indicates a true positive where the model predicts that the patient has psoriasis and the patient actually has the disease. FP represents a false positive, and FN denotes a false negative. Due to data imbalance in the dataset, the F1 score and the area under the precision-recall curve (AUPRC) better summarize biomarkers and reflect model performance (<xref ref-type="bibr" rid="B20">20</xref>). All ML models were built with the &#x201c;mlr3verse&#x201d; package. The &#x201c;modEVA 3.11&#x201d; package was utilized to calculate the F1 score and AUPRC.</p>
</sec>
<sec id="s2_2_2">
<label>2.2.2</label>
<title>Explainable ML model</title>
<p>After summarizing the F1 score and AUPRC for each model, we selected the most suitable model for identifying and interpreting the disease. SHapley Additive exPlanations (SHAP) is a method to explain ML models and address their black-box issue (<xref ref-type="bibr" rid="B21">21</xref>). Shapley values originate from the cooperative game theory field, which can be used to assess the interaction/joint effect of two features and calculate the importance of a feature by quantifying the marginal impact (<xref ref-type="bibr" rid="B22">22</xref>). Shapviz (version 0.9.2) package was used to give local explanations and allow computation of the contribution of each variable to each individual&#x2019;s prediction by Shapley values. We use SHAP beeswarm plots to visualize the results of the selected models.</p>
</sec>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Mendelian randomization</title>
<sec id="s2_3_1">
<label>2.3.1</label>
<title>Basic concept of MR analysis</title>
<p>Mendelian randomization (MR) is a method using measured genetic variants (single nucleotide polymorphisms [SNPs]) as instrumental variables (IV) to examine an exposure&#x2019;s causal effect on an outcome (<xref ref-type="bibr" rid="B23">23</xref>). Compared to traditional observational methods, MR analysis is less vulnerable to bias from reverse causation and confounding. We performed a two-sample MR analysis to validate the association of each component of circs with psoriasis. Furthermore, a reverse MR analysis was performed to avoid any chance of reverse causality.</p>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>Data sources</title>
<p>Our MR analyses used publicly available summary statistics from large-scale GWAS datasets. Data for WC and hypertension were obtained from MRC-IEU UK Biobank OpenGWAS (<xref ref-type="bibr" rid="B24">24</xref>), which included 462,166 and 462,933 European individuals. Genetic variants associated with FBG (<xref ref-type="bibr" rid="B25">25</xref>) and depression symptoms (<xref ref-type="bibr" rid="B26">26</xref>) were extracted from a joint meta-analysis of GWAS in 58,074 and 807,553 individuals, respectively. The summary level exposure datasets for triglycerides (<xref ref-type="bibr" rid="B27">27</xref>), HDL-C (<xref ref-type="bibr" rid="B28">28</xref>), and short sleep (<xref ref-type="bibr" rid="B29">29</xref>) were extracted from UKBiobank by three different research groups. As to psoriasis (9,267 cases, 364,071 controls), the summary statistics were obtained from the FinnGen consortium&#x2019;s R9 release of GWAS data (<xref ref-type="bibr" rid="B30">30</xref>). All subjects were of European descent. Age, sex, and other major variables were taken into account during the analyses of these data. Specific information is listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1.</bold>
</xref>
</p>
</sec>
<sec id="s2_3_3">
<label>2.3.3</label>
<title>Selection of SNPs for MR analysis</title>
<p>The genetic variants used for this MR analyses need to satisfy three assumptions: (1) the genetic variants must be strongly correlated with the components of CircS; (2) the genetic variant is independent of any potential confounders between CircS and psoriasis; (3) the genetic variants affect the psoriasis only through the components of CircS. To fulfill these three assumptions, we used several quality assurance procedures for IV selection: (1) Candidate IVs were picked from SNPs associated with the components of CircS at the locus-wide significance threshold of <italic>P</italic>&lt; 5 &#xd7; 10<sup>-8</sup>. Clumping parameters included a linkage disequilibrium (LD) threshold of <italic>R</italic>
<sup>2</sup>&lt; 0.01 and a window size of 10,000 kb. The LD value was calculated using the European-based 1,000 Genome Project (<xref ref-type="bibr" rid="B31">31</xref>) as a reference, and SNPs that did not meet the requirements were removed; (2) we used the PhenoScanner GWAS database (<xref ref-type="bibr" rid="B32">32</xref>) to verify all selected SNPs and removed SNPs associated significantly with any potential confounder at the genome-wide level; (3) the remaining SNPs were extracted from the psoriasis datasets and calculated F-statistics (<xref ref-type="bibr" rid="B33">33</xref>) for each SNP to quantify the strength of the psoriasis. IVs with F<italic>-</italic>values&lt; 10 were regarded as weak and were excluded.</p>
</sec>
<sec id="s2_3_4">
<label>2.3.4</label>
<title>MR analysis</title>
<p>We chose four MR methods, including inverse variance weighted (IVW), MR-Egger, weighted median (WM), and maximum likelihood (ML) for two-sample MR analyses. For SNPs without horizontal pleiotropy, the IVW method is the primary tool for calculating causal effect values to produce unbiased estimates. The remaining three methods were used as secondary methods to correct for pleiotropy. Several sensitivity analyses were conducted to assess whether this analysis violates the MR assumptions and determine the results&#x2019; reliability and validity. Cochrane&#x2019;s <italic>Q</italic> test was applied to ascertain the heterogeneity among SNPs associated with each component of CircS. If there was heterogeneity, we used a random-effect IVW model; otherwise, the fixed-effect IVW model was performed (<xref ref-type="bibr" rid="B34">34</xref>). We ran MR-Egger regressions and MR-PRESSO analyses to rule out potential pleiotropy. Finally, a leave-one-out approach was used to examine the possible impacts of pleiotropic SNPs on the causal estimates by repeating analyses after removing one SNP at a time. We used TwoSampleMR (version 0.5.8) (<xref ref-type="bibr" rid="B35">35</xref>) and MRPRESSO (version 1.0) packages for MR and sensitivity analysis.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Baseline characteristics of NHANES</title>
<p>A total of 9,531 participants were eligible and divided into four groups by MetS and CircS in these four cycles. As shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>, most baseline characteristics showed significant differences between the groups. Participants with MetS or CircS were older (MetS: 57.0 [45.0;68.0]; CircS: 56.0 [45.0;67.0]) and more likely to be smoking (MetS: 50%; CircS: 51.3%) status. Psoriasis was more common in both MetS (3.76%) and CircS (3.88%) and more prevalent among CircS participants. By definition, CircS participants differed more from MetS participants regarding sleep duration and depression symptoms. Specifically, participants in CircS had less sleep (MetS: 41.8%; CircS: 56.8%) and were more depressed (MetS: 30.8%; CircS: 43.7%) than those in MetS. In particular, among depressive symptoms, the CircS group was more severe than the MetS group in all phases. We also tested the reliability of some of the covariates after multiple imputations. There were no statistical differences among covariates in 4 replications (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristics of participants by categories of MetS and CircS: NHANES 2005&#x2013;2006 and 2009&#x2013;2014.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="center">Variables</th>
<th valign="middle" rowspan="2" align="center">All (n=9531)</th>
<th valign="top" colspan="2" align="center">MetS group</th>
<th valign="middle" rowspan="2" align="center">
<italic>P</italic>
</th>
<th valign="top" colspan="2" align="center">CircS group</th>
<th valign="middle" rowspan="2" align="center">P</th>
</tr>
<tr>
<th valign="top" align="center">MetS (n=4338)</th>
<th valign="top" align="center">Non-MetS (n=5193)</th>
<th valign="top" align="center">CircS (n=3634)</th>
<th valign="top" align="center">Non-CircS (n=5897)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (mean (SD))</td>
<td valign="top" align="left">50.0 [36.0;63.0]</td>
<td valign="top" align="left">57.0 [45.0;68.0]</td>
<td valign="top" align="left">43.0 [30.0;56.0]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">56.0 [45.0;67.0]</td>
<td valign="top" align="left">44.0 [31.0;60.0]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Age group</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;20&#x2013;39</td>
<td valign="top" align="left">2978 (31.2%)</td>
<td valign="top" align="left">704 (16.2%)</td>
<td valign="top" align="left">2274 (43.8%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">594 (16.3%)</td>
<td valign="top" align="left">2384 (40.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;40&#x2013;69</td>
<td valign="top" align="left">3494 (36.7%)</td>
<td valign="top" align="left">1664 (38.4%)</td>
<td valign="top" align="left">1830 (35.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1462 (40.2%)</td>
<td valign="top" align="left">2032 (34.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;60+</td>
<td valign="top" align="left">3059 (32.1%)</td>
<td valign="top" align="left">1970 (45.4%)</td>
<td valign="top" align="left">1089 (21.0%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1578 (43.4%)</td>
<td valign="top" align="left">1481 (25.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">0.023</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male</td>
<td valign="top" align="left">4741 (49.7%)</td>
<td valign="top" align="left">2102 (48.5%)</td>
<td valign="top" align="left">2639 (50.8%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1683 (46.3%)</td>
<td valign="top" align="left">3058 (51.9%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female</td>
<td valign="top" align="left">4790 (50.3%)</td>
<td valign="top" align="left">2236 (51.5%)</td>
<td valign="top" align="left">2554 (49.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1951 (53.7%)</td>
<td valign="top" align="left">2839 (48.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Race</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Mexican American</td>
<td valign="top" align="left">1473 (15.5%)</td>
<td valign="top" align="left">707 (16.3%)</td>
<td valign="top" align="left">766 (14.8%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">598 (16.5%)</td>
<td valign="top" align="left">875 (14.8%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Other Hispanic</td>
<td valign="top" align="left">892 (9.36%)</td>
<td valign="top" align="left">408 (9.41%)</td>
<td valign="top" align="left">484 (9.32%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">351 (9.66%)</td>
<td valign="top" align="left">541 (9.17%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Non-Hispanic White</td>
<td valign="top" align="left">4202 (44.1%)</td>
<td valign="top" align="left">1956 (45.1%)</td>
<td valign="top" align="left">2246 (43.3%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1585 (43.6%)</td>
<td valign="top" align="left">2617 (44.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Non-Hispanic Black</td>
<td valign="top" align="left">2003 (21.0%)</td>
<td valign="top" align="left">937 (21.6%)</td>
<td valign="top" align="left">1066 (20.5%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">830 (22.8%)</td>
<td valign="top" align="left">1173 (19.9%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Other Race</td>
<td valign="top" align="left">961 (10.1%)</td>
<td valign="top" align="left">330 (7.61%)</td>
<td valign="top" align="left">631 (12.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">270 (7.43%)</td>
<td valign="top" align="left">691 (11.7%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Income to poverty ratio</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Low</td>
<td valign="top" align="left">3137 (32.9%)</td>
<td valign="top" align="left">1562 (36.0%)</td>
<td valign="top" align="left">1575 (30.3%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1396 (38.4%)</td>
<td valign="top" align="left">1741 (29.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Moderate</td>
<td valign="top" align="left">3498 (36.7%)</td>
<td valign="top" align="left">1602 (36.9%)</td>
<td valign="top" align="left">1896 (36.5%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1311 (36.1%)</td>
<td valign="top" align="left">2187 (37.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;High</td>
<td valign="top" align="left">2896 (30.4%)</td>
<td valign="top" align="left">1174 (27.1%)</td>
<td valign="top" align="left">1722 (33.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">927 (25.5%)</td>
<td valign="top" align="left">1969 (33.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Education</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;High school or less</td>
<td valign="top" align="left">4463 (46.8%)</td>
<td valign="top" align="left">2289 (52.8%)</td>
<td valign="top" align="left">2174 (41.9%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1940 (53.4%)</td>
<td valign="top" align="left">2523 (42.8%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Some college</td>
<td valign="top" align="left">2874 (30.2%)</td>
<td valign="top" align="left">1336 (30.8%)</td>
<td valign="top" align="left">1538 (29.6%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1134 (31.2%)</td>
<td valign="top" align="left">1740 (29.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;College graduate or higher</td>
<td valign="top" align="left">2194 (23.0%)</td>
<td valign="top" align="left">713 (16.4%)</td>
<td valign="top" align="left">1481 (28.5%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">560 (15.4%)</td>
<td valign="top" align="left">1634 (27.7%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Smoking status</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Never</td>
<td valign="top" align="left">5188 (54.4%)</td>
<td valign="top" align="left">2169 (50.0%)</td>
<td valign="top" align="left">3019 (58.1%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1772 (48.8%)</td>
<td valign="top" align="left">3416 (57.9%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Former</td>
<td valign="top" align="left">2383 (25.0%)</td>
<td valign="top" align="left">1283 (29.6%)</td>
<td valign="top" align="left">1100 (21.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1049 (28.9%)</td>
<td valign="top" align="left">1334 (22.6%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Now</td>
<td valign="top" align="left">1960 (20.6%)</td>
<td valign="top" align="left">886 (20.4%)</td>
<td valign="top" align="left">1074 (20.7%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">813 (22.4%)</td>
<td valign="top" align="left">1147 (19.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Drinking status</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">4546 (47.7%)</td>
<td valign="top" align="left">2242 (51.7%)</td>
<td valign="top" align="left">2304 (44.4%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1886 (51.9%)</td>
<td valign="top" align="left">2660 (45.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">4985 (52.3%)</td>
<td valign="top" align="left">2096 (48.3%)</td>
<td valign="top" align="left">2889 (55.6%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1748 (48.1%)</td>
<td valign="top" align="left">3237 (54.9%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">BMI (kg/m2) (mean (SD))</td>
<td valign="top" align="left">29.5 (6.95)</td>
<td valign="top" align="left">33.1 (6.88)</td>
<td valign="top" align="left">26.5 (5.45)</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">33.3 (7.06)</td>
<td valign="top" align="left">27.2 (5.75)</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">WC</td>
<td valign="top" align="left">100 (16.7)</td>
<td valign="top" align="left">110 (14.8)</td>
<td valign="top" align="left">92.1 (13.3)</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">111 (15.2)</td>
<td valign="top" align="left">94.1 (14.3)</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Triglycerides</td>
<td valign="top" align="left">110 [74.0;171]</td>
<td valign="top" align="left">165 [110;237]</td>
<td valign="top" align="left">85.0 [61.0;116]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">171 [115;245]</td>
<td valign="top" align="left">89.0 [64.0;124]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Direct HDL-C</td>
<td valign="top" align="left">50.0 [42.0;61.0]</td>
<td valign="top" align="left">44.0 [37.0;52.0]</td>
<td valign="top" align="left">56.0 [48.0;66.0]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">43.0 [37.0;52.0]</td>
<td valign="top" align="left">55.0 [46.0;65.0]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Plasma glucose</td>
<td valign="top" align="left">101 [93.0;116]</td>
<td valign="top" align="left">114 [102;141]</td>
<td valign="top" align="left">95.0 [89.0;101]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">114 [102;143]</td>
<td valign="top" align="left">96.0 [90.0;104]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Systolic pressure</td>
<td valign="top" align="left">121 [111;133]</td>
<td valign="top" align="left">127 [117;139]</td>
<td valign="top" align="left">116 [108;126]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">127 [116;139]</td>
<td valign="top" align="left">117 [109;128]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Diastolic pressure</td>
<td valign="top" align="left">69.3 [62.0;76.7]</td>
<td valign="top" align="left">71.3 [62.7;79.3]</td>
<td valign="top" align="left">68.7 [62.0;74.7]</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">71.3 [63.3;79.3]</td>
<td valign="top" align="left">68.7 [62.0;75.3]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Sleep time</td>
<td valign="top" align="left">7.00 [6.00;8.00]</td>
<td valign="top" align="left">7.00 [6.00;8.00]</td>
<td valign="top" align="left">7.00 [6.00;8.00]</td>
<td valign="top" align="left">0.169</td>
<td valign="top" align="left">6.00 [5.00;8.00]</td>
<td valign="top" align="left">7.00 [6.00;8.00]</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Elevated WC</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">3913 (41.1%)</td>
<td valign="top" align="left">503 (11.6%)</td>
<td valign="top" align="left">3410 (65.7%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">427 (11.8%)</td>
<td valign="top" align="left">3486 (59.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">5618 (58.9%)</td>
<td valign="top" align="left">3835 (88.4%)</td>
<td valign="top" align="left">1783 (34.3%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">3207 (88.2%)</td>
<td valign="top" align="left">2411 (40.9%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Elevated blood pressure</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">4444 (46.6%)</td>
<td valign="top" align="left">802 (18.5%)</td>
<td valign="top" align="left">3642 (70.1%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">659 (18.1%)</td>
<td valign="top" align="left">3785 (64.2%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">5087 (53.4%)</td>
<td valign="top" align="left">3536 (81.5%)</td>
<td valign="top" align="left">1551 (29.9%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">2975 (81.9%)</td>
<td valign="top" align="left">2112 (35.8%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Elevated FBG</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">4291 (45.0%)</td>
<td valign="top" align="left">620 (14.3%)</td>
<td valign="top" align="left">3671 (70.7%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">549 (15.1%)</td>
<td valign="top" align="left">3742 (63.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">5240 (55.0%)</td>
<td valign="top" align="left">3718 (85.7%)</td>
<td valign="top" align="left">1522 (29.3%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">3085 (84.9%)</td>
<td valign="top" align="left">2155 (36.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Elevated triglycerides</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">6432 (67.5%)</td>
<td valign="top" align="left">1750 (40.3%)</td>
<td valign="top" align="left">4682 (90.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1338 (36.8%)</td>
<td valign="top" align="left">5094 (86.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">3099 (32.5%)</td>
<td valign="top" align="left">2588 (59.7%)</td>
<td valign="top" align="left">511 (9.84%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">2296 (63.2%)</td>
<td valign="top" align="left">803 (13.6%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Reduced HDL-C</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">6573 (69.0%)</td>
<td valign="top" align="left">1982 (45.7%)</td>
<td valign="top" align="left">4591 (88.4%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1528 (42.0%)</td>
<td valign="top" align="left">5045 (85.6%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">2958 (31.0%)</td>
<td valign="top" align="left">2356 (54.3%)</td>
<td valign="top" align="left">602 (11.6%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">2106 (58.0%)</td>
<td valign="top" align="left">852 (14.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Sleep &#x2264; 6 h/day</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">5720 (60.0%)</td>
<td valign="top" align="left">2526 (58.2%)</td>
<td valign="top" align="left">3194 (61.5%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">1570 (43.2%)</td>
<td valign="top" align="left">4150 (70.4%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">3811 (40.0%)</td>
<td valign="top" align="left">1812 (41.8%)</td>
<td valign="top" align="left">1999 (38.5%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">2064 (56.8%)</td>
<td valign="top" align="left">1747 (29.6%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Depression symptoms</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;None-minimal</td>
<td valign="top" align="left">7122 (74.7%)</td>
<td valign="top" align="left">3002 (69.2%)</td>
<td valign="top" align="left">4120 (79.3%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">2046 (56.3%)</td>
<td valign="top" align="left">5076 (86.1%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Mild</td>
<td valign="top" align="left">1514 (15.9%)</td>
<td valign="top" align="left">775 (17.9%)</td>
<td valign="top" align="left">739 (14.2%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">940 (25.9%)</td>
<td valign="top" align="left">574 (9.73%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Moderate</td>
<td valign="top" align="left">543 (5.70%)</td>
<td valign="top" align="left">326 (7.51%)</td>
<td valign="top" align="left">217 (4.18%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">388 (10.7%)</td>
<td valign="top" align="left">155 (2.63%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Moderately Severe</td>
<td valign="top" align="left">247 (2.59%)</td>
<td valign="top" align="left">162 (3.73%)</td>
<td valign="top" align="left">85 (1.64%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">182 (5.01%)</td>
<td valign="top" align="left">65 (1.10%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Severe</td>
<td valign="top" align="left">105 (1.10%)</td>
<td valign="top" align="left">73 (1.68%)</td>
<td valign="top" align="left">32 (0.62%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">78 (2.15%)</td>
<td valign="top" align="left">27 (0.46%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">Psoriasis</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="left">9243 (97.0%)</td>
<td valign="top" align="left">4175 (96.2%)</td>
<td valign="top" align="left">5068 (97.6%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">3493 (96.1%)</td>
<td valign="top" align="left">5750 (97.5%)</td>
<td valign="top" align="left">
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="left">288 (3.02%)</td>
<td valign="top" align="left">163 (3.76%)</td>
<td valign="top" align="left">125 (2.41%)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">141 (3.88%)</td>
<td valign="top" align="left">147 (2.49%)</td>
<td valign="top" align="left">
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Use student t-test for normal distribution data and the Mann-Whitney U test for skewed distribution data in continuity variables. Categorical variables were compared using the chi-square test. MetS, Metabolic Syndrome; CircS, Circadian Syndrome; BMI, body mass index; WC, waist circumference; HDL-C, high density lipoprotein cholesterol; FBG, fasting blood glucose</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Multivariate regression analysis</title>
<p>Sample-weighted multiple regression analyses in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> showed a positive relationship between CircS with psoriasis prevalence in the non-adjusted model (OR = 1.48, 95%CI: 1.09&#x2013;1.99, <italic>P</italic> = 0.012), the minimally adjusted model (OR = 1.40, 95%CI: 1.03&#x2013;1.91, <italic>P</italic> = 0.033) and the fully adjusted model (OR = 1.40, 95%CI: 1.02&#x2013;1.91, <italic>P</italic> = 0.039). There was also a positive correlation between MetS and psoriasis, with OR of 1.59 (95%CI: 1.12&#x2013;2.26, <italic>P</italic> = 0.01), 1.48 (95%CI: 1.04&#x2013;2.11, <italic>P</italic> = 0.031), and 1.53 (95%CI: 1.07&#x2013;2.17, <italic>P</italic> = 0.02) for prevalent psoriasis in the three models, respectively. These three models were further employed to investigate the association between the CircS components with psoriasis in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>. Psoriasis prevalence was found to be promoted by elevated blood pressure (OR<sub>non-adjusted</sub> = 1.65, <italic>P</italic>
<sub>non-adjusted</sub> = 0.006; OR<sub>minimally adjusted</sub> = 1.58, <italic>P</italic>
<sub>minimally adjusted</sub> = 0.009; OR<sub>fully adjusted</sub> = 1.58, <italic>P</italic>
<sub>fully adjusted</sub> = 0.009) and depression symptoms in all three models. The OR of depression symptoms was greater in moderately severe (OR<sub>non-adjusted</sub> = 2.61, <italic>P</italic>
<sub>non-adjusted</sub> = 0.01; OR<sub>minimally adjusted</sub> = 2.72, <italic>P</italic>
<sub>minimally adjusted</sub> = 0.009; OR<sub>fully adjusted</sub> = 2.69, <italic>P</italic>
<sub>fully adjusted</sub> = 0.01) than in mild (OR<sub>non-adjusted</sub> = 1.61, <italic>P</italic>
<sub>non-adjusted</sub> = 0.02; OR<sub>minimally adjusted</sub> = 1.66, <italic>P</italic>
<sub>minimally adjusted</sub> = 0.01; OR<sub>fully adjusted</sub> = 1.68, <italic>P</italic>
<sub>fully adjusted</sub> = 0.01). In the minimally and fully adjusted models, the risk of psoriasis was 1.24 and 1.20 times greater in those with elevated WC, respectively, with <italic>P</italic> of 0.024 and 0.023, compared to those without. The remaining components showed no statistically significant association with the prevalent psoriasis.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Association of MetS and CircS with the prevalence rates of psoriasis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="center">Variables</th>
<th valign="top" colspan="2" align="center">Non-adjusted model*</th>
<th valign="top" colspan="2" align="center">Minimally adjusted model**</th>
<th valign="top" colspan="2" align="center">Fully adjusted model***</th>
</tr>
<tr>
<th valign="top" align="center">OR (95%CI)</th>
<th valign="top" align="center">P</th>
<th valign="top" align="center">OR (95%CI)</th>
<th valign="top" align="center">P</th>
<th valign="top" align="center">OR (95%CI)</th>
<th valign="top" align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" align="left" colspan="7">Circadian syndrome</th>
</tr>
<tr>
<td valign="top" align="center">No</td>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">Yes</td>
<td valign="top" align="center">1.48(1.09&#x2013;1.99)</td>
<td valign="top" align="center">0.012</td>
<td valign="top" align="center">1.40(1.03&#x2013;1.91)</td>
<td valign="top" align="center">0.033</td>
<td valign="top" align="center">1.40(1.02&#x2013;1.91)</td>
<td valign="top" align="center">0.039</td>
</tr>
<tr>
<th valign="top" align="left" colspan="7">Metabolic syndrome</th>
</tr>
<tr>
<td valign="top" align="center">No</td>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
<td valign="top" align="center">Ref</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">Yes</td>
<td valign="top" align="center">1.59(1.12&#x2013;2.26)</td>
<td valign="top" align="center">0.010</td>
<td valign="top" align="center">1.48(1.04&#x2013;2.11)</td>
<td valign="top" align="center">0.031</td>
<td valign="top" align="center">1.53(1.07&#x2013;2.17)</td>
<td valign="top" align="center">0.020</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*Non-adjusted model adjusted no factor. **Minimally adjusted model adjusted age, gender, and race. ***Fully adjusted model adjusted age, gender, race, educational level, family income, smoking status, and drinking status. OR, odds ratio; CI, confidence interval.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Association of the components of circadian syndrome with the prevalence of psoriasis in three multiple logistic regression models. OR: odds ratio; CI: confidence interval. * <italic>P</italic>&lt; 0.05, ** <italic>P</italic>&lt; 0.01. Non-adjusted model adjusted no factor. Minimally adjusted model adjusted age, gender, and race. Fully adjusted model adjusted age, gender, race, educational level, family income, smoking status, and drinking status.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1379130-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Model performance comparison</title>
<p>We generated five algorithms to predict the probability of psoriasis using each MetS or CircS component, respectively. <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> displays the AUPRC curves of the five models on the test set to demonstrate their discriminant performance. Among the five models in CircS, CatBoost (AUPRC = 0.969) has the best prediction effect on psoriasis, followed by LightGBM (AUPRC= 0.901), XGBoost (AUPRC = 0.85), KNN (AUPRC = 0.735), and SVM (AUPRC = 0.704). Predicting psoriasis using MetS had similar results, with CatBoost (AUPRC = 0.907) having the best performance, followed by LightGBM (AUPRC= 0.873), XGBoost (AUPRC = 0.772), KNN (AUPRC = 0.608), and SVM (AUPRC = 0.582). Comparing the performance of CircS components and MetS components in each algorithm, we find that CircS components outperform MetS components in every algorithm. Components of CircS are better predictors of psoriasis in these algorithms. The recall, precision, F1 scores, AUPRC, and 95%CI of AUPRC for all five ML models are shown in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>. <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref> shows the differences between AUPRC compared pairwise for all models. The 95% bootstrap CI for this difference was calculated. Each 95% bootstrap CI does not include 0, implying that there are differences in each of the AUPRCs being compared.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Precision-recall curve from five models for circadian syndrome (CircS) and Metabolic Syndrome (MetS) in predicting psoriasis. KNN, k-nearest neighbor classification; SVM, support vector machine; XGBoost, eXtreme Gradient Boosting; LightGBM, Light Gradient Boosting Machine; CatBoost, Categorical Features+Gradient Boosting.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1379130-g003.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Model performance metrics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Models</th>
<th valign="top" align="center">Recall</th>
<th valign="top" align="center">Precision</th>
<th valign="top" align="center">F1</th>
<th valign="top" align="center">AUPRC</th>
<th valign="top" align="center">95% CI</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">CatBoost_CircS</td>
<td valign="top" align="center">0.908</td>
<td valign="top" align="center">0.925</td>
<td valign="top" align="center">0.916</td>
<td valign="top" align="center">0.969</td>
<td valign="top" align="center">0.952&#x2013;0.981</td>
</tr>
<tr>
<td valign="top" align="center">CatBoost_MetS</td>
<td valign="top" align="center">0.857</td>
<td valign="top" align="center">0.864</td>
<td valign="top" align="center">0.861</td>
<td valign="top" align="center">0.907</td>
<td valign="top" align="center">0.880&#x2013;0.927</td>
</tr>
<tr>
<td valign="top" align="center">XGBoost_CircS</td>
<td valign="top" align="center">0.719</td>
<td valign="top" align="center">0.851</td>
<td valign="top" align="center">0.78</td>
<td valign="top" align="center">0.852</td>
<td valign="top" align="center">0.821&#x2013;0.878</td>
</tr>
<tr>
<td valign="top" align="center">XGBoost_MetS</td>
<td valign="top" align="center">0.54</td>
<td valign="top" align="center">0.768</td>
<td valign="top" align="center">0.634</td>
<td valign="top" align="center">0.772</td>
<td valign="top" align="center">0.736&#x2013;0.803</td>
</tr>
<tr>
<td valign="top" align="center">LightGBM_CircS</td>
<td valign="top" align="center">0.795</td>
<td valign="top" align="center">0.871</td>
<td valign="top" align="center">0.831</td>
<td valign="top" align="center">0.901</td>
<td valign="top" align="center">0.875&#x2013;0.923</td>
</tr>
<tr>
<td valign="top" align="center">LightGBM_MetS</td>
<td valign="top" align="center">0.726</td>
<td valign="top" align="center">0.829</td>
<td valign="top" align="center">0.774</td>
<td valign="top" align="center">0.873</td>
<td valign="top" align="center">0.844&#x2013;0.897</td>
</tr>
<tr>
<td valign="top" align="center">KNN_CircS</td>
<td valign="top" align="center">0.853</td>
<td valign="top" align="center">0.78</td>
<td valign="top" align="center">0.815</td>
<td valign="top" align="center">0.846</td>
<td valign="top" align="center">0.815&#x2013;0.873</td>
</tr>
<tr>
<td valign="top" align="center">KNN_MetS</td>
<td valign="top" align="center">0.729</td>
<td valign="top" align="center">0.789</td>
<td valign="top" align="center">0.758</td>
<td valign="top" align="center">0.819</td>
<td valign="top" align="center">0.786&#x2013;0.848</td>
</tr>
<tr>
<td valign="top" align="center">SVM_CircS</td>
<td valign="top" align="center">0.452</td>
<td valign="top" align="center">0.727</td>
<td valign="top" align="center">0.647</td>
<td valign="top" align="center">0.704</td>
<td valign="top" align="center">0.665&#x2013;0.738</td>
</tr>
<tr>
<td valign="top" align="center">SVM_MetS</td>
<td valign="top" align="center">0.334</td>
<td valign="top" align="center">0.609</td>
<td valign="top" align="center">0.586</td>
<td valign="top" align="center">0.582</td>
<td valign="top" align="center">0.543&#x2013;0.622</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>CircS, Circadian Syndrome; MetS, Metabolic Syndrome; AUPRC, area under the precision-recall curve; CI, confidence interval; KNN, k-nearest neighbor classification; SVM, support vector machine; XGBoost, eXtreme Gradient Boosting; LightGBM, Light Gradient Boosting Machine; CatBoost, Categorical Features+Gradient Boosting</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Visualization of feature importance</title>
<p>Combined with <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>, each component of circs using the CatBoost algorithm predicted psoriasis performance best. We perform SHAP model interpretation and feature importance visualization for this model. The SHAP variable importance and beeswarm plot (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>) present the comprehensive impact of each feature on psoriasis, with features arranged in descending order based on their significance. A positive SHAP value signifies a positive correlation between the value of a feature and the prevalence of psoriasis. Larger values contribute more to the prediction of psoriasis. Among the components of CircS, elevated blood pressure, depression symptoms, elevated WC, and short sleep contributed more to the prediction of psoriasis. Elevated blood pressure, depression symptoms, and elevated WC were positively associated with the prevalence of psoriasis, whereas short sleep was not significantly different in the figure.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Global explainability beeswarm plots of the CatBoost model for predicting psoriasis by each component of CircS. CatBoost, Categorical Features+Gradient Boosting; CircS, Circadian Syndrome.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1379130-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>MR of CircS and psoriasis</title>
<p>After filtering according to the above selection standard, the number of IVs for WC, hypertension, FBG, triglycerides, HDL-C, depression symptoms, and short sleep were 456; 252; 18; 334; 50; 41; and 42, respectively. Abnormal IVs were removed through MR-PRESSO global outlier test, and F-statistics for all IVs exceeded 10, ranging from 28.77 to 2059.43 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). Cochran&#x2019;s Q test in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;5</bold>
</xref> indicated significant heterogeneity in WC, hypertension, triglycerides, and HDL-C. Therefore, a multiplicative random-effects model was utilized for these four IVW analyses. Under the IVW model in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, there were asignificant causal relationships between WC (OR = 1.52, 95%CI: 1.34&#x2013;1.73, <italic>P</italic> = 1.35e<sup>-10</sup>), hypertension (OR = 1.68, 95%CI: 1.19&#x2013;2.37, <italic>P</italic> = 0.003), depression symptoms (OR = 1.39, 95%CI: 1.17&#x2013;1.65, <italic>P</italic> = 1.51e<sup>-4</sup>), and short sleep (OR = 2.03, 95%CI: 1.21&#x2013;3.39, <italic>P</italic> = 0.007) with psoriasis risk, while no causal relationship was found for FBG, triglycerides, and HDL-C. The remaining three methods further validated the results. The sensitivity analysis results showed that the p-value of MR-Egger intercept between the selected instruments was less than 0.05 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;5</bold>
</xref>), which indicates that the associations were not affected by significant horizontal pleiotropy. As determined by the leave-one-out analyses, no single SNP significantly affected the results for each component of CircS, ensuring the reliability of the results (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Moreover, the results of reverse MR analyses indicate no reverse associations of genetic susceptibility to the components of CircS with psoriasis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;6</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The results of Mendelian randomization analyses for the causal association between the components of CircS and MetS with psoriasis. CircS, Circadian Syndrome; MetS, Metabolic Syndrome.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1379130-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>This cross-sectional study examined the link between MetS, CircS, and their components with psoriasis risk in US adults. It also compared the predictive power of CircS and MetS in identifying psoriasis via machine learning. Our results revealed that CircS and its components were positively associated with the prevalence of psoriasis. CircS was a better predictor for prevalent psoriasis than Mets, with elevated blood pressure, depression symptoms, and elevated WC contributing more to the prediction. These results were further confirmed in MR analyses.</p>
<p>Similar to the majority of literature on MetS as an intrinsic risk factor for psoriasis (<xref ref-type="bibr" rid="B36">36</xref>), we found that MetS increases the prevalence of psoriasis. Combining the effects of sleep disorders and depression on psoriasis, we noted the new concept of CircS. The circadian system regulates a wide range of bodily processes, including gene expression, hormone release, and energy expenditure, among many other critical physical processes, and is essential to maintaining human health and metabolism (<xref ref-type="bibr" rid="B37">37</xref>). Circadian rhythms play a crucial part in glucose and insulin regulation (<xref ref-type="bibr" rid="B38">38</xref>). Several studies have found that imbalances in circadian rhythms not only lead to metabolic disorders such as obesity but also exacerbate depression symptoms (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>), which explains the increase of depression in MetS. CircS provides a better explanation of the MetS itself and its comorbidities, such as sleep disturbances and depression. Thus, CircS may better cover the symptoms of psoriasis patients. As we speculate, CircS was positively associated with psoriasis in this study, with a higher proportion of CircS participants having psoriasis and better performance predicting psoriasis than MetS.</p>
<p>Elevated blood pressure, depression symptoms, elevated WC, and short sleep were more important in predicting psoriasis in the optimal ML model as interpreted by SHAP. The MR analyses further verified the causality of these results. Unfortunately, logistic regression did not show significance for short sleep. Elevated blood pressure and elevated WC are components shared by MetS and CircS. In a large national cohort study totaling 256,356 participants over 11 years, psoriasis incidence was higher in participants with hypertension, and the results were still significant after adjustment for confounders (<xref ref-type="bibr" rid="B41">41</xref>). Hypertension and psoriasis may be related to a common inflammatory pathway. Inflammation contributes to the development of hypertension through a complex interplay involving immune cells, cytokines, and oxidative stress (<xref ref-type="bibr" rid="B42">42</xref>). Accumulating evidence suggests that low-grade chronic inflammation plays a significant role in the initiation and maintenance of essential hypertension (<xref ref-type="bibr" rid="B43">43</xref>). Long-term stimulation by chronic inflammation can lead to vascular remodeling and endothelial dysfunction, promote immune cell activation, and accumulate reactive oxygen species (ROS), contributing to elevated blood pressure (<xref ref-type="bibr" rid="B44">44</xref>). Psoriasis is similarly afflicted by ROS, associated with increased ROS production and decreased antioxidant potential, leading to oxidative stress and damage to cell components (<xref ref-type="bibr" rid="B45">45</xref>). ROS is a significant factor in the development and progression of hypertension and psoriasis, contributing to the chronic inflammatory processes and immune dysregulation associated with the condition.</p>
<p>Several epidemiological investigations have confirmed that obesity is a risk factor for psoriasis, especially centripetal obesity characterized by elevated WC (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). White adipose tissue (WAT) expansion is central to obesity, responding to caloric surplus through unhealthy expansion, leading to obesity-related complications (<xref ref-type="bibr" rid="B48">48</xref>). The expansion of WAT in obesity is accompanied by inflammation of the adipose tissue, which eventually develops into chronic low-grade systemic inflammation. In addition to the chronic inflammatory state of obesity, the adipokine leptin, which regulates energy balance and metabolism in adipose tissue, has been implicated in developing psoriasis. It is highly expressed in psoriasis skin lesions and serum (<xref ref-type="bibr" rid="B49">49</xref>). These inflammatory responses involving various cytokines, chemokines, and hormones secreted by different types of adipose tissue cells ultimately lead to an immune disorder similar to psoriasis.</p>
<p>Depression symptoms and short sleep are components unique to CircS. Our results indicate that depression symptoms were a strong predictor of psoriasis, with an increased risk as the severity of the depression symptoms worsened. Depression was found to be independently associated with an increased risk of psoriasis in a large prospective cohort of US women (<xref ref-type="bibr" rid="B50">50</xref>). Two MR studies found the same results (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). It has recently been discovered that depression has an inflammatory pattern similar to psoriasis. Overactivation of microglia in a depressed mouse model leads to differentiation of T cells into Th17 cells, an increase in cytokines such as IL-17 and IL-6, and a decrease in Treg. When the model mice were treated with IL-17A, the level of inflammation was equalized, IL-10 was upregulated, and the number of Treg increased. The depression symptoms of mice gradually alleviate (<xref ref-type="bibr" rid="B53">53</xref>). However, the relationship between depression and psoriasis still lacks support from high-quality randomized controlled trials. Although short sleep had a causal effect on psoriasis in MR and contributed to the prediction of psoriasis, the results of SHAP visualization and logistic regression were not significant. Short sleep and psoriasis can also be linked through inflammatory networks, particularly tumor necrosis factor-&#x3b1; and IL-6, related to psoriasis pathogenesis and sleep regulation (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>The present study has several strengths. Firstly, our study exploring the relationship between MetS and CircS with psoriasis had a relatively large sample size. Logistic regression results combined with MR analyses clarified the direction of causality, and the results were made more robust by avoiding confounding factors. Secondly, We use five ML algorithms to compare the performance of MetS and CircS for predicting psoriasis and explain the best-performing model. As far as we know, no research has been conducted on the correlation between CircS and the prevalence of psoriasis. The study also has several limitations. First, the cross-sectional design meant that variables could not be extracted strictly to our specific needs, such as psoriasis and sleep duration were self-reported rather than obtained by diagnosis and precise measurement. We defined participants with PHQ-9 scores greater than 5 as depression symptoms and did not use mild depression with PHQ-9 scores greater than 10, which better summarizes the psychological state of anxiety or depression. At the same time, the cycles included in the study lacked surveys on taking medication for depression due to the different questionnaires for each cycle. Second, in contrast to the cross-sectional study on a multiethnic US population, our MR analyses focused on individuals of European ancestry. Individual ethnic studies are also needed to eliminate potential confounding by heterogeneity across populations. Third, although we performed MR analyses between the components of CircS and psoriasis to test their respective causal effects, we still had difficulty determining the direction of CircS and psoriasis due to the lack of a GWAS database for CircS.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>To summarize, both the MetS and CircS were positively associated with psoriasis in NHANES data from 4 cycles. Moreover, CircS demonstrated superior predictive ability for prevalent psoriasis compared to MetS, with elevated blood pressure, depression symptoms, and elevated WC contributing more to the prediction. We should keep a close watch on the risk of psoriasis with CircS in the presence of these three components. The introduction of the concept of CircS has refined risk management in psoriasis.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>YG: Conceptualization, Software, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XY: Resources, Writing &#x2013; original draft. WTZ: Software, Visualization, Writing &#x2013; original draft. SH: Data curation, Resources, Writing &#x2013; original draft. WMZ: Resources, Validation, Writing &#x2013; original draft. XZ: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Hubei TCM Administration 2023&#x2013;2024 TCM Research Project (ZY2023Z012).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We want to thank all the participants and investigators in the FinnGen consortium and National Health and Nutrition Examination Survey for publicly available data.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1379130/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1379130/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.pdf" id="SF1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parisi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Iskandar</surname> <given-names>IYK</given-names>
</name>
<name>
<surname>Kontopantelis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Augustin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Griffiths</surname> <given-names>CEM</given-names>
</name>
<name>
<surname>Ashcroft</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study</article-title>. <source>BMJ</source>. (<year>2020</year>) <volume>369</volume>:<elocation-id>m1590</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.m1590</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Saalbach</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Psoriasis: obesity and fatty acids</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>1807</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01807</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Controne</surname> <given-names>I</given-names>
</name>
<name>
<surname>Scoditti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Buja</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pacifico</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kridin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fabbro</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>Do sleep disorders and western diet influence psoriasis? A scoping review</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<elocation-id>4324</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu14204324</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Skov</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Psoriasis and obesity</article-title>. <source>Dermatology</source>. (<year>2016</year>) <volume>232</volume>:<page-range>633&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000455840</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname> <given-names>NN</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Joshi</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Dey</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Armstrong</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Duffin</surname> <given-names>KC</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial</article-title>. <source>Circ Cardiovasc Imaging</source>. (<year>2018</year>) <volume>11</volume>:<fpage>e007394</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCIMAGING.117.007394</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Bioinformatic analysis of the potential common pathogenic mechanisms for psoriasis and metabolic syndrome</article-title>. <source>Inflammation</source>. (<year>2023</year>) <volume>46</volume>:<page-range>1381&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-023-01815-4</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>W-Q</given-names>
</name>
<name>
<surname>Qureshi</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Schernhammer</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Rotating night-shift work and risk of psoriasis in US women</article-title>. <source>J Invest Dermatol</source>. (<year>2013</year>) <volume>133</volume>:<page-range>565&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/jid.2012.285</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewinson</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Vallerand</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Lowerison</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Parsons</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Frolkis</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>GG</given-names>
</name>
<etal/>
</person-group>. <article-title>Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: A population-based study</article-title>. <source>J Invest Dermatol</source>. (<year>2017</year>) <volume>137</volume>:<page-range>828&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jid.2016.11.032</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheikh-Ali</surname> <given-names>M</given-names>
</name>
<name>
<surname>Maharaj</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Circadian clock desynchronisation and metabolic syndrome</article-title>. <source>Postgrad Med J</source>. (<year>2014</year>) <volume>90</volume>:<page-range>461&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/postgradmedj-2013-132366</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sargheini</surname> <given-names>N</given-names>
</name>
<name>
<surname>Birkenbihl</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moiseeva</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fr&#xf6;hlich</surname> <given-names>H</given-names>
</name>
<name>
<surname>Golubnitschaja</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies</article-title>. <source>EPMA J</source>. (<year>2020</year>) <volume>11</volume>:<page-range>517&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13167-020-00229-8</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmet</surname> <given-names>P</given-names>
</name>
<name>
<surname>Alberti</surname> <given-names>KGMM</given-names>
</name>
<name>
<surname>Stern</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bilu</surname> <given-names>C</given-names>
</name>
<name>
<surname>El-Osta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Einat</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The Circadian Syndrome: is the Metabolic Syndrome and much more</article-title>! <source>J Intern Med</source>. (<year>2019</year>) <volume>286</volume>:<page-range>181&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/joim.12924</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Tuomilehto</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kronfeld-Schor</surname> <given-names>N</given-names>
</name>
<name>
<surname>Alberti</surname> <given-names>G</given-names>
</name>
<name>
<surname>Stern</surname> <given-names>N</given-names>
</name>
<name>
<surname>El-Osta</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The Circadian Syndrome Is a Significant and Stronger Predictor for Cardiovascular Disease than the Metabolic Syndrome-The NHANES Survey during 2005-2016</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<elocation-id>5317</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu14245317</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Relationship between circadian syndrome and stroke: A cross-sectional study of the national health and nutrition examination survey</article-title>. <source>Front Neurol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>946172</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fneur.2022.946172</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between the prevalence rates of circadian syndrome and testosterone deficiency in US males: data from NHANES (2011-2016)</article-title>. <source>Front Nutr</source>. (<year>2023</year>) <volume>10</volume>:<elocation-id>1137668</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2023.1137668</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azur</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Stuart</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Frangakis</surname> <given-names>C</given-names>
</name>
<name>
<surname>Leaf</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Multiple imputation by chained equations: what is it and how does it work</article-title>? <source>Int J Methods Psychiatr Res</source>. (<year>2011</year>) <volume>20</volume>:<page-range>40&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mpr.329</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberti</surname> <given-names>KGMM</given-names>
</name>
<name>
<surname>Eckel</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Grundy</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Zimmet</surname> <given-names>PZ</given-names>
</name>
<name>
<surname>Cleeman</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Donato</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity</article-title>. <source>Circulation</source>. (<year>2009</year>) <volume>120</volume>:<page-range>1640&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192644</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroenke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Spitzer</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>JB</given-names>
</name>
</person-group>. <article-title>The PHQ-9: validity of a brief depression severity measure</article-title>. <source>J Gen Intern Med</source>. (<year>2001</year>) <volume>16</volume>:<page-range>606&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults</article-title>. <source>JAMA Dermatol</source>. (<year>2022</year>) <volume>158</volume>:<fpage>745</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamadermatol.2022.1609</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Panesar</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Machine learning algorithms</article-title>. In: <source>Machine learning and AI for healthcare : big data for improved health outcomes</source>. <publisher-name>Apress</publisher-name>, <publisher-loc>Berkeley, CA</publisher-loc> (<year>2021</year>). p. <fpage>85</fpage>&#x2013;<lpage>144</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4842-6537-6_4</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozenne</surname> <given-names>B</given-names>
</name>
<name>
<surname>Subtil</surname> <given-names>F</given-names>
</name>
<name>
<surname>Maucort-Boulch</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The precision&#x2013;recall curve overcame the optimism of the receiver operating characteristic curve in rare diseases</article-title>. <source>J Clin Epidemiol</source>. (<year>2015</year>) <volume>68</volume>:<page-range>855&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jclinepi.2015.02.010</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Lundberg</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S-I</given-names>
</name>
</person-group>. <article-title>A unified approach to interpreting model predictions</article-title>. <conf-name>Proceedings of the 31st International Conference on Neural Information Processing Systems (NIPS&#x2019; 17)</conf-name>. <publisher-loc>Red Hook, NY, USA</publisher-loc>: <publisher-name>Curran Associates Inc</publisher-name>. (<year>2017</year>). p. <page-range>4768&#x2013;77</page-range>. </citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Roth</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>The Shapley Value: Essays in Honor of Lloyd S. Shapley</article-title>. <publisher-loc>Cambridg; New York</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name> (<year>1988</year>).</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanderson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Glymour</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>J</given-names>
</name>
<name>
<surname>Munaf&#xf2;</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>Mendelian randomization</article-title>. <source>Nat Rev Methods Primers</source>. (<year>2022</year>) <volume>2</volume>:<elocation-id>6</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s43586-021-00092-5</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsworth</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lyon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alexander</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Matthews</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hallett</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The MRC IEU OpenGWAS data infrastructure</article-title>. <source>bioRxiv</source>. (<year>2020</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2020.08.10.244293</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Hivert</surname> <given-names>M-F</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Grimsby</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Bouatia-Naji</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance</article-title>. <source>Nat Genet</source>. (<year>2012</year>) <volume>44</volume>:<page-range>659&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng.2274</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname> <given-names>Dm</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>Mj</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>Tk</given-names>
</name>
<name>
<surname>Hafferty</surname> <given-names>Jd</given-names>
</name>
<name>
<surname>Gibson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shirali</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions</article-title>. <source>Nat Neurosci</source>. (<year>2019</year>) <volume>22</volume>:<page-range>343&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41593-018-0326-7</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaue</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kanai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tanigawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Karjalainen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kurki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Koshiba</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A cross-population atlas of genetic associations for 220 human phenotypes</article-title>. <source>Nat Genet</source>. (<year>2021</year>) <volume>53</volume>:<page-range>1415&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41588-021-00931-x</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Leyden</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Elsworth</surname> <given-names>B</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation</article-title>. <source>PloS Biol</source>. (<year>2022</year>) <volume>20</volume>:<elocation-id>e3001547</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.3001547</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Dashti</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Aragam</surname> <given-names>KG</given-names>
</name>
<name>
<surname>van Hees</surname> <given-names>VT</given-names>
</name>
<etal/>
</person-group>. <article-title>Biological and clinical insights from genetics of insomnia symptoms</article-title>. <source>Nat Genet</source>. (<year>2019</year>) <volume>51</volume>:<page-range>387&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41588-019-0361-7</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurki</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Karjalainen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Palta</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sipil&#xe4;</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Kristiansson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Donner</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>FinnGen: Unique genetic insights from combining isolated population and national health register data</article-title>. <source>medRxiv</source>. (<year>2022</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2022.03.03.22271360</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zheng-Bradley</surname> <given-names>X</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kulesha</surname> <given-names>E</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Toneva</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>The 1000 Genomes Project: data management and community access</article-title>. <source>Nat Methods</source>. (<year>2012</year>) <volume>9</volume>:<page-range>459&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.1974</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staley</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Blackshaw</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kamat</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Ellis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Surendran</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>BB</given-names>
</name>
<etal/>
</person-group>. <article-title>PhenoScanner: a database of human genotype-phenotype associations</article-title>. <source>Bioinformatics</source>. (<year>2016</year>) <volume>32</volume>:<page-range>3207&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btw373</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>SG</given-names>
</name>
<collab>CRP CHD Genetics Collaboration</collab>
</person-group>. <article-title>Avoiding bias from weak instruments in Mendelian randomization studies</article-title>. <source>Int J Epidemiol</source>. (<year>2011</year>) <volume>40</volume>:<page-range>755&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ije/dyr036</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Thompson SB Simon</surname> <given-names>G</given-names>
</name>
</person-group>. <source>Mendelian randomization: methods for causal inference using genetic variants</source>. <edition>2nd ed</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>Chapman and Hall/CRC</publisher-name> (<year>2021</year>). p. <fpage>240</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1201/9780429324352</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemani</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Elsworth</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wade</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Haberland</surname> <given-names>V</given-names>
</name>
<name>
<surname>Baird</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>The MR-Base platform supports systematic causal inference across the human phenome</article-title>. <source>Elife</source>. (<year>2018</year>) <volume>7</volume>:<elocation-id>e34408</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.34408</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamiya</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kishimoto</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sugai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Komine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ohtsuki</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Risk factors for the development of psoriasis</article-title>. <source>Int J Mol Sci</source>. (<year>2019</year>) <volume>20</volume>:<elocation-id>4347</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20184347</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orozco-Solis</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Epigenetic control and the circadian clock: linking metabolism to neuronal responses</article-title>. <source>Neuroscience</source>. (<year>2014</year>) <volume>264</volume>:<fpage>76</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.01.043</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenvers</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Scheer</surname> <given-names>FAJL</given-names>
</name>
<name>
<surname>Schrauwen</surname> <given-names>P</given-names>
</name>
<name>
<surname>la</surname>
</name>
<name>
<surname>Kalsbeek</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Circadian clocks and insulin resistance</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2019</year>) <volume>15</volume>:<fpage>75</fpage>&#x2013;<lpage>89</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41574-018-0122-1</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hittle</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Caruso</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lambert</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gillespie</surname> <given-names>GL</given-names>
</name>
</person-group>. <article-title>Nurse health: the influence of chronotype and shift timing</article-title>. <source>West J Nurs Res</source>. (<year>2020</year>) <volume>42</volume>:<page-range>1031&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0193945920916802</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wyse</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Celis Morales</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>J</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Adverse metabolic and mental health outcomes associated with shiftwork in a population-based study of 277,168 workers in UK biobank</article-title>. <source>Ann Med</source>. (<year>2017</year>) <volume>49</volume>:<page-range>411&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07853890.2017.1292045</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>H-N</given-names>
</name>
<name>
<surname>Han</surname> <given-names>K</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S-W</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study</article-title>. <source>PloS One</source>. (<year>2018</year>) <volume>13</volume>:<elocation-id>e0202854</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0202854</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiffrin</surname> <given-names>EL</given-names>
</name>
</person-group>. <article-title>The immune system: role in hypertension</article-title>. <source>Can J Cardiol</source>. (<year>2013</year>) <volume>29</volume>:<page-range>543&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cjca.2012.06.009</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youwakim</surname> <given-names>J</given-names>
</name>
<name>
<surname>Girouard</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Inflammation: A mediator between hypertension and neurodegenerative diseases</article-title>. <source>Am J Hypertens</source>. (<year>2021</year>) <volume>34</volume>:<page-range>1014&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ajh/hpab094</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>13</volume>:<elocation-id>1098725</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.1098725</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuguchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gotoh</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Setoyama</surname> <given-names>D</given-names>
</name>
<name>
<surname>Takata</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ohga</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial reactive oxygen species are essential for the development of psoriatic inflammation</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>714897</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.714897</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snekvik</surname> <given-names>I</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Nilsen</surname> <given-names>TIL</given-names>
</name>
<name>
<surname>Langan</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Modalsli</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Romundstad</surname> <given-names>PR</given-names>
</name>
<etal/>
</person-group>. <article-title>Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study</article-title>. <source>J Invest Dermatol</source>. (<year>2017</year>) <volume>137</volume>:<page-range>2484&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jid.2017.07.822</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Qureshi</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Obesity, waist circumference, weight change and the risk of psoriasis in US women</article-title>. <source>J Eur Acad Dermatol Venereol</source>. (<year>2013</year>) <volume>27</volume>:<page-range>1293&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jdv.12001</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinonen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jokinen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rissanen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pietil&#xe4;inen</surname> <given-names>KH</given-names>
</name>
</person-group>. <article-title>White adipose tissue mitochondrial metabolism in health and in obesity</article-title>. <source>Obes Rev</source>. (<year>2020</year>) <volume>21</volume>:<elocation-id>e12958</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/obr.12958</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerman</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Bozkurt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sav</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tulunay</surname> <given-names>A</given-names>
</name>
<name>
<surname>Elba&#x15f;i</surname> <given-names>MO</given-names>
</name>
<name>
<surname>Ergun</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Serum leptin levels, skin leptin and leptin receptor expression in psoriasis</article-title>. <source>Br J Dermatol</source>. (<year>2008</year>) <volume>159</volume>:<page-range>820&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/bjd.2008.159.issue-4</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ascherio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Qureshi</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Depression and the risk of psoriasis in US women</article-title>. <source>J Eur Acad Dermatol Venereol</source>. (<year>2013</year>) <volume>27</volume>:<page-range>1163&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1468-3083.2012.04703.x</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two-sample Mendelian randomization study</article-title>. <source>J Dermatol</source>. (<year>2023</year>) <volume>50</volume>:<page-range>1629&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1346-8138.16941</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Bidirectional association between psoriasis and depression: Two longitudinal follow-up studies using a national sample cohort</article-title>. <source>J Affect Disord</source>. (<year>2020</year>) <volume>262</volume>:<page-range>126&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jad.2019.10.043</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>K-A</given-names>
</name>
</person-group>. <article-title>Interleukin-17 induced by cumulative mild stress promoted depression-like behaviors in young adult mice</article-title>. <source>Mol Brain</source>. (<year>2021</year>) <volume>14</volume>:<elocation-id>11</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13041-020-00726-x</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garbarino</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lanteri</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bragazzi</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Magnavita</surname> <given-names>N</given-names>
</name>
<name>
<surname>Scoditti</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Role of sleep deprivation in immune-related disease risk and outcomes</article-title>. <source>Commun Biol</source>. (<year>2021</year>) <volume>4</volume>:<fpage>1304</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-021-02825-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>